5,919 followers
RT @migrainefanz: Pharmac in NZ weigh up ‘costs and savings’ when deciding to fund a new drug. Here’s some evidence - treating migraine wit…
RT @migrainefanz: Pharmac in NZ weigh up ‘costs and savings’ when deciding to fund a new drug. Here’s some evidence - treating migraine wit…
Pharmac in NZ weigh up ‘costs and savings’ when deciding to fund a new drug. Here’s some evidence - treating migraine with a CGRP monoclonal antibody improves absenteeism, presenteeism and work productivity. Can we get them funded please? https://t.co/I1d